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Abstract
Background: Wnt signaling is implicated in many developmental decisions, including stem cell
control, as well as in cancer. There are relatively few target genes known of the Wnt pathway.
Results: We have identified target genes of Wnt signaling using microarray technology and human
embryonic carcinoma cells stimulated with active Wnt protein. The ~50 genes upregulated early
after Wnt addition include the previously known Wnt targets Cyclin D1, MYC, ID2 and β TRCP.
The newly identified targets, which include MSX1, MSX2, Nucleophosmin, Follistatin, TLE/
Groucho, Ubc4/5E2, CBP/P300, Frizzled and REST/NRSF, have important implications for
understanding the roles of Wnts in development and cancer. The protein synthesis inhibitor
cycloheximide blocks induction by Wnt, consistent with a requirement for newly synthesized β -
catenin protein prior to target gene activation. The promoters of nearly all the target genes we
identified have putative TCF binding sites, and we show that the TCF binding site is required for
induction of Follistatin. Several of the target genes have a cooperative response to a combination
of Wnt and BMP.
Conclusions:  Wnt signaling activates genes that promote stem cell fate and inhibit cellular
differentiation and regulates a remarkable number of genes involved in its own signaling system.
Background
There is currently great interest in using extracellular sign-
aling proteins to influence the gene expression program
and differentiation of embryonic cells, in particular em-
bryonic stem cells. Of the factors that contribute to speci-
fying cell fate during development, Wnt proteins are
among the most attractive candidates to use in such in vit-
ro experiments. Wnt proteins control numerous aspects of
development, ranging from stem cell control to differenti-
ation and cell polarity [1,2]. It has been problematic how-
ever to test directly whether Wnt proteins can be used as
reagents in cell culture, because working with soluble Wnt
proteins is difficult and few cell lines are known to re-
spond to Wnt proteins. Wnt signal transduction proceeds
through a complex series of protein interactions, initiated
by binding of the Wnt protein to cell surface receptors
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(Frizzled and LRP [3–5]) which generates a signal to
downstream components. A key event in signaling is the
regulation of the GSK3 protein kinase and its substrate β -
catenin. In the absence of a Wnt signal, GSK3 phosphor-
ylates β -catenin, which then becomes targeted for degra-
dation [6]. The binding of Wnt to its receptors initiates a
cascade of events that inhibit GSK3 and ultimately pre-
vent degradation of β -catenin. Together with the DNA
binding protein TCF, β -catenin activates expression of
Wnt target genes. In this work, we have identified Wnt tar-
get genes using micro-array technology.
Results
Identifying Wnt targets on microarrays
We tested human teratocarcinoma cells (NCCIT) cells for
a Wnt response. Despite the cancerous origin of these
cells, they share many properties with embryonic stem
cells [7]. These cells express several members of the Friz-
zled family (including FZD7), one of the receptors for
Wnt (data not shown; Figure 2A). To stimulate the NCCIT
cells with Wnt, we used tissue culture medium containing
active Wnt-3A protein produced by mouse L cells (Wnt-3A
CM [8]), in comparison to control conditioned medium
(CCM). In initial experiments, we found that Wnt-3A pro-
tein elevates the levels of β -catenin 5–10 fold (Figure 4);
and that a transiently transfected TCF reporter construct is
activated 3–4 fold (not shown).
To identify target genes, we applied Wnt-3A CM or CCM
to the NCCIT cells and isolated RNA at several time
points. We performed differential hybridization to micro-
array slides containing approximately 23,000 spots of hu-
man cDNAs, using RNA from CCM-exposed cells as a
reference. Figure 1 shows a cluster analysis of the hybridi-
zation results. We found approximately 50 genes that
were upregulated between 2 and 10 fold by Wnt-3A CM
whereas a few genes were repressed, i.e. expressed at lower
levels in the Wnt-3A-treated cells. The latter group consist-
ed mostly of ESTs of unknown genes and has yet to be
characterized.
We verified Wnt-induced expression of several genes with
Northern blots (Figure 2). In all cases tested, we con-
firmed the increase observed in the microarray; in some
cases we found even higher differences in expression. For
example, MSX2, ID2, REST/NRSF, FZD7 and Follistatin
were confirmed by Northern analysis to be significantly
elevated by Wnt-3A CM after two hours (Figure 2A).
None of these genes was induced by the CCM, suggesting
that they are Wnt-specific. It remained possible however
that the observed changes in gene expression were influ-
enced by other differences between Wnt-3A CM and
CCM. For example, Wnt-3A could have induced the ex-
pression of another secreted factor in the mouse L cells
which would then be present only in the Wnt-3A CM. We
addressed this possibility by specifically removing active
Wnt-3A from the conditioned medium, using a combina-
tion of the ligand binding domain of the Drosophila Wnt/
Wingless receptor Frizzled-2 fused to Alkaline Phos-
phatase [3,9] and Wnt-3A specific antibodies. This proce-
Figure 1
Microarray cluster analysis demonstrating increased expres-
sion of Wnt-3A responsive genes, including MSX1, MSX2,
ID2, Versican, NPM, Frizzled-7, TLE/Groucho, Cyclin D1,
and MYC. NCCIT cells were exposed to control conditioned
medium (CCM) and Wnt-3A CM [8] for 4 hours. Shown
here are 5 separate experiments. Note also that MSX 2 is
included on this particular array in duplicate which provides
an internal check on the precision of the measurements.
Additional array experiments led to the identification of Fol-
listatin and REST/NRSF as elevated genes (which were con-
firmed in Figure 2A). Brightest red corresponds to ratio of =
2:1 and dimmer red corresponds to ratio of 2:1. The full data
set will be available at the Wnt homepage  [http://www.stan-
ford.edu/~rnusse/wntwindow.html] and the Stanford Micro-
array database  [http://genome-www5.stanford.edu/
MicroArray/SMD/]
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dure specifically depleted active Wnt-3A from the
medium. As expected, neither β -catenin levels nor a TCF
reporter gene were elevated by the depleted CM (not
shown). The depleted medium also failed to induce
MSX1, MSX2, ID2 and CyclinD1 expression as assayed by
Northern blots (Figure 2B shows loss of MSX1) and in a
DNA microarray analysis with CCM as a reference (not
shown). Similarly, adding Dickkopf protein, an inhibitor
of Wnt signaling that binds to the co-receptor LRP [10], to
the medium abrogated the transcriptional response (data
not shown). We conclude that the transcriptional re-
sponse to Wnt-3A CM is indeed controlled by the Wnt-3A
protein rather than by other factors.
Cooperativity between Wnt-3A and BMP
Several of the Wnt target genes had been identified previ-
ously as targets of BMP signaling [11]. We were therefore
interested in comparing the effects of BMP and Wnt-3A
and examining their combined effects. As has been report-
ed before for other cells [11], MSX1, MSX2 and ID2 are el-
evated by BMP-4 in NCCIT cells (Figure 3). When Wnt-3A
and BMP-4 were combined, gene expression was in-
creased to yet higher levels. MSX1 expression was marked-
ly elevated by the combination of BMP-4 and Wnt-3A.
Similar but less dramatic effects were found for ID2 and
MSX2 (Figure 3). Hence, BMP-4 and Wnt-3A appear to
have an additive or perhaps synergistic effect on target
gene expression. However, when the time courses of Wnt-
and BMP-induced gene expression were compared, it ap-
peared that BMP-4 acts as soon as at 30 minutes, but that
Wnt takes 2 hours to have an effect (Figure 3). Hence,
Wnt-induced changes in gene expression are slower than
BMP, even on the same target genes and in the same cell
type.
Wnt signaling is blocked by cycloheximide
The delay in transcriptional response to soluble Wnt
raised the concern that the genes we identified might not
be primary targets of Wnt but dependent on the prior in-
duction of other genes. Such concerns are usually ad-
dressed by blocking protein synthesis in cells because the
expression of primary target genes, or so-called immediate
early genes, should not be sensitive whereas secondary
targets should be blocked. This approach is not readily ap-
plicable to the Wnt response because the critical step in
signal transduction is the block in β -catenin phosphoryla-
tion and degradation, leading to the accumulation of
newly-synthesized β -catenin. Whether Wnt target gene ac-
tivation is cycloheximide sensitive has never been tested
however. When we incubated cells with cycloheximide,
the accumulation of β -catenin by Wnt-3A was blocked;
and Wnt targets, like MSX2, were not elevated (Figure 4).
The inhibitory effect was also seen for MSX1, ID2, Follista-
tin, Versican and Cyclin D1 (not shown). In contrast, cy-
cloheximide did not block induction of target genes by
BMP (Figure 4), the mechanism of which does not involve
protein accumulation [12]. These findings underscore the
importance of β -catenin protein elevation in the response
to Wnt. This unique aspect of Wnt signaling may explain
its relatively slow effects on target genes – protein synthe-
sis is slower than protein phosphorylation or other signal
transduction events.
Figure 2
A) Confirmation of microarray data using Northern analysis.
Northern blot analysis using MSX2, ID2, REST/NRSF, FZD7
(Frizzled7) and Follistatin cDNA probes. NCCIT cells were
treated with CCM (-) or Wnt-3A CM (+) for the designated
number of hours. 1 ug mRNA was loaded into each lane.
GAPDH is shown as a sample loading control. B) MSX1
induction by Wnt-3A CM is dependent on the presence of
soluble Wnt-3A protein. C = CCM. Wnt = Wnt-3A CM.
Wnt-depleted = Wnt-3A CM. Cells were incubated with the
various media for 4 hours.
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The requirement for protein synthesis in Wnt signaling
means that we cannot use cycloheximide sensitivity as a
criterion to discriminate between primary and secondary
targets.
The Follistatin promoter is dependent on a TCF binding 
site
In the Wnt target gene promoters that are functionally
mapped (MSX1, MSX2, ID2, ID3, Follistatin, REST/NRSF,
Versican) we invariably found TCF binding sites. Moreo-
ver, we found that a luciferase reporter gene, placed under
the control of the Follistatin promoter, was activated by
Wnt-3A protein added to transiently transfected NCCIT
cells (Figure 5). Mutating the single TCF binding site on
the Follistatin promoter eliminated the response. These
data suggest that Follistatin is activated directly through
the Wnt signal transduction pathway and not by another
pathway. Because the kinetics of Follistatin activation by
Wnt are similar to that of the other target genes (Figure
2A), we suggest that there are no "earlier" targets, i.e. all
identified targets are direct.
Discussion
The overall pattern of gene expression observed in re-
sponse to Wnt has important implications for the role of
Wnt signaling in development and cancer. Of particular
interest are the ID, MSX, and REST/NRSF genes. Expres-
sion of each of these genes can interfere with differentia-
tion of cells. ID2 was recently shown also to be a target of
activated β -catenin in colon carcinoma cells [13]. It is a
Figure 3
Time course of Wnt induced gene expression and cooperation with BMP. NCCIT cells were exposed to Wnt-3A CM, BMP-4
(10 ng/ml final concentration) or the combination of Wnt-3A and BMP-4 for the specified number of hours. Shown here are
MSX1, MSX2 and ID2 demonstrating that Wnt-3A induced effects are not seen until 2 hours (which corresponds to β -catenin
accumulation). BMP-4 mediated induction of MSX1, MSX2 and ID2 occurs rapidly, as early as 30 minutes and stays relatively
constant. Cooperative effects of Wnt-3A and BMP-4 are not evident until approximately 2 hours. The height of the bars
presents the ratio induced/non-induced, quantified by phosphoimager analysis of Northern blots and normalized to GAPDH
expression measured in the same experiment. Each bar represents average values obtained from 3–5 experiments for each
mRNA tested.
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general inhibitor of the bHLH proteins such as MyoD and
E12/E47 [14] and can interact with the tumor suppressor
RB1 [15]. MSX1 expression can revert differentiated myo-
tubes into an undifferentiated state [16]. REST/NRSF is
known to block neural differentiation by binding to and
inhibiting the expression of neuronal genes [17,18]. To
what extent these genes are controlled by Wnt signaling in
intact animals or in other cell types is not clear yet, but we
do note that MSX mutants have phenotypes similar to
LEF/TCF mutants [19,20].
The MSX and ID genes are also activated by BMP [11] and
we found indeed synergistic effects of Wnt plus BMP.
There are several examples of interactions between BMP
and Wnt family members in vivo, particularly in Dro-
sophila [21] and this cross-talk adds to the potential of
these pathways for cell type specification. However, Wnt
signaling also promotes the expression of such genes as
Cyclin D1 [22] and MYC [23], which are not elevated by
BMP. The ability to block differentiation and simultane-
ously promote cell division is a distinctive characteristic of
Wnt signaling which could be instrumental in the role of
Wnts as stem cell growth factors, such as in the crypt of the
colon, and in carcinogenesis [2,24,25].
Several of the Wnt targets genes encode components of
the Wnt signaling transduction system. The increased ex-
pression of β TrCP/slimb [26] and the ubiquitin conjugat-
ing enzyme Ubc4/5E2 (Figure 1), both involved in
degradation of β -catenin [27], could act as a negative feed-
back loop in Wnt signaling. Moreover, Frizzled receptors,
Versican and other proteoglycans which contribute to
Wnt protein activity are also controlled by Wnt signaling,
as previously described in Drosophila [28,29]. At the level
of transcriptional regulation, we found up-regulation of
CBP/P300, which partners with β -catenin [30,31] but also
TLE/Groucho, which is an inhibitor of TCF function [32].
These responses suggest a rich system of homeostasis and
feedback control mechanisms, but they complicate the in-
terpretation of experimental studies of Wnt signal trans-
duction in which the time course of induction cannot be
controlled easily.
The delayed response to Wnt signaling raises interesting
developmental issues. Timing of gene expression is very
important during embryogenesis. A slow response is likely
to be an important feature of the activity of Wnts as mor-
phogens, when not only the concentration but also the
duration of the stimulus is important. In considering
these issues, it is of interest to note that in the early C. el-
egans embryo, Wnt signaling proceeds through a non-ca-
nonical pathway, through phosphorylation of the TCF
homolog but not using the increase in β -catenin [33]. Cell
divisions and polarization in the worm embryo occur on
a time scale of minutes, and the different mechanism of
Wnt signaling in that context may be more suitable than
the inherently slower translation-dependent β -catenin in-
crease.
Conclusions
We found that Wnt signaling can activate genes that pro-
mote stem cell fate and inhibit cellular differentiation;
and regulates a remarkable number of genes involved in
its own signaling system. The overall pattern of gene ex-
pression provides clues to the diverse functions of Wnt
proteins in cancer, cell fate decisions and other develop-
mental events.
Methods
Cells
Mouse L cells secreting Wnt-3A were established in our
lab, by transfecting expression constructs in which the
Wnt-3A cDNA [34] is driven by the PGK promoter. In or-
der to get cells secreting relatively high amounts of Wnt-
3A, we selected clones from the transfected cell popula-
tion. The tissue culture supernatant was added to NCCIT
cells [7].
Figure 4
A) Western blot demonstrating cycloheximide effects of
Wnt-3A mediated accumulation of β -catenin. NCCIT cells
were stimulated for 4 hours with CCM (C) or Wnt-3A CM
(Wnt) in the presence (20 microgram/ml) or absence (0) of
cycloheximide. Note that β -catenin does not accumulate in
response to Wnt-3A CM when cycloheximide is present. B)
Northern analysis demonstrating that MSX2 induction by
Wnt-3A is abolished in the presence of cycloheximide. Cells
were stimulated for 4 hours with CCM (C), BMP-4 or Wnt-
3A CM (Wnt) in the presence (20 microgram/ml media) or
absence of cycloheximide. As expected, BMP-4 mediated
induction of MSX2 is not affected by cycloheximide which
contrasts with the inhibition of Wnt-3A mediated induction
of MSX2 in the presence of cycloheximide. GAPDH was
used to verify equal loading. The inhibitory effect was also
seen for MSX1, ID2, Follistatin, Versican and Cyclin D1 (not
shown).
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Hybrizations and array experiments
mRNA isolated from Wnt-3A exposed cells was reverse
transcribed and labeled with Cy5 (red) and cDNA from
CCM treated cells labeled with Cy3 (green). Samples from
induced and control NCCIT cells were mixed and co-hy-
bridized to array slides containing 22,648 different hu-
man cDNAs, representing 17,083 different Unigene
clusters and including 7,230 characterized genes. Hybrid-
ized arrays were imaged using a GenPix (Axon) scanner
and data were analyzed by hierarchical clustering [35].
Depletion of Wnt protein
The medium was specifically depleted of Wnt-3A by add-
ing an excess of a fusion protein containing the cysteine-
rich domain of the Frizzled2 receptor of Drosophila
(which binds to Wnt-3A protein) and alkaline phos-
phatase. [9]. By adding antibody to alkaline phosphatase,
all of the detectable Wnt-3A protein could be removed
from the medium. In addition, an antibody to Wnt-3A it-
self was used for depletion, although it worked less effi-
ciently than the Frizzled fusion protein
Mutating the Follistatin promoter
The Follistatin promoter [36] contains one putative TCF
binding site (CTTTGAT) at position -223 to -217 from the
start of transcription. This site was mutated into CATC-
GAT, which led to abrogation of the Wnt-3A response.
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